The administration of US president Joe Biden is said to be wrangling with the Republican opposition in Congress to preserve funding for key components of the federal coronavirus response as the two sides fight over raising the debt ceiling to avert a government shutdown.
Just before the New Year, the administration of US president Joe Biden revived Waters of the United States, a section of former president Barack Obama’s Clean Air Act that had been deleted by Donald Trump in a move rejected by a federal court.
The administration of US president Joe Biden is looking for ways to work around the Supreme Court’s recent landmark ruling that limits the Environmental Protection Agency’s role in regulating emissions of greenhouse gases.
The US Supreme Court is holding a special session today, Jan. 7, to deliberate on whether the administration of president Joe Biden can enforce a vaccine-or-test mandate for large private companies and a vaccine mandate for many healthcare workers. The review, which reflects inconclusive lower court decisions, is a departure from the normal proceeding of reviewing challenges to a binding verdict.
The US Senate has narrowly voted, 48 to 52, in favor of a Republican Party resolution to block president Joe Biden’s Covid-19 vaccine mandate for companies employing 100 people or more. Two conservative senators from Biden’s Democratic Party voted with the opposition.
In a decision that could sound a cautionary note for other countries hoping to boost Covid-19 vaccination numbers this way, a US appellate court has put a temporary hold on US president Joe Biden’s plan to introduce a vaccine mandate through an executive order called the Emergency Temporary Standard on Vaccination and Testing (ETS).
As part of his proposal for discretionary spending in the US government’s fiscal year 2022, President Joe Biden has proposed $6.5 billion in funding to establish a new federal agency within the National Institutes of Health (NIH) to drive bio-pharmaceutical innovation in areas such as cancer, diabetes and Alzheimer’s disease.
